4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001680329-25-000004
Director sold 15,705 shares at $59.50 ($934,448)
- Director acquired 10,837 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Reeve Emma · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-11 | Sale : show line 1 in the form 10b5-1 | −3,534 | $59.50 | $210,273 | 11,666 | D |
| 2025-09-11 | Sale : show line 2 in the form 10b5-1 | −1,334 | $59.50 | $79,373 | 10,332 | D |
| 2025-09-11 | Exercise or conversion : show line 3 in the form 10b5-1 | +10,000 | $25.69 | $256,900 | 20,332 | D |
| 2025-09-11 | Sale : show line 4 in the form 10b5-1 | −10,000 | $59.50 | $595,000 | 10,332 | D |
| 2025-09-11 | Exercise or conversion : show line 5 in the form 10b5-1 | +837 | $33.63 | $28,148 | 11,169 | D |
| 2025-09-11 | Sale : show line 6 in the form 10b5-1 | −837 | $59.50 | $49,802 | 10,332 | D |
| Open-market sales · 15,705 sh · avg $59.50 · $934,448 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-11 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −10,000 | 0 | D |
| 2025-09-11 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −837 | 0 | D |
Loading xslF345X05/form4-09162025_050903.xml…